Conferences & Events News
Preliminary final report: Strong analytica reinforces leading position
6th Annual Achieving Quality & Process Excellence in the Pharmaceutical Industry
15-17 September 2010, Lisbon, Portugal.What are the best practices to achieve QC Laboratory Excellence? How successful are you in adopting and sustaining consistent, harmonized & compliant quality systems?
The Brussels Pharmaceuticals Conference 2010
The Brussels Pharmaceuticals Conference will be held on the 5th May 2010. This high-level event will provide a unique opportunity for key stakeholders to discuss the current developments in European pharmaceutical policy.
Last Call for Med-e-Tel 2010 Early Bird Registration
The Med-e-Tel forum is the ideal opportunity to follow up on the latest developments and initiatives in Telemedicine and eHealth and to exchange ideas and experiences related to ICT applications in healthcare. Register on or before Monday, 15th March, 2010 and get the early bird rate for your Med-e-Tel registration.
Final Line-Up for the Inaugural Health 2.0 Conference in Europe
Health 2.0 Europe will take place at the Cité Internationale Universitaire in Paris. This event will feature the three integral components of Health 2.0 in a rapid-fire live demo format where leading examples of Health 2.0 in North America will be compared and contextualized with the latest in European innovation.
Web Innovators, Pharma, Insurance and Government Converge to Speak at Health 2.0 Europe
Health 2.0 Europe, a conference dedicated to how Web 2.0 and social media are transforming healthcare systems in Europe, has finalized its agenda and speaker list. Encompassing all aspects of the healthcare chain, the interactive program will address healthcare on both country- and European-wide levels, with local experts from converging industries.
More Pharma News ...
Business & Industry
- Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
- Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
- Bayer Consumer Health leaders propose new principles for science-led self-care
- GSK signs agreement to support pandemic preparedness in Europe
- Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
Research & Development
- New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
- Research identifies, exploits vulnerability in certain high-risk cancers
- Scientists create long-acting injectable drug delivery system for tuberculosis
- Treating cancer by sticking cells in place
- Vitamin K prevents cell death: a new function for a long-known molecule
- Disparities in United States COVID-19 vaccine distribution
- New needle-free nasal vaccine shows promise for COVID-19
Conferences & Events
- New approach to treatment of deadly kidney cancer
- SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
- Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
- SMi's 22nd Annual Pain Therapeutics Conference
- SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
- SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
- SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
- FDA approves first systemic treatment for alopecia areata
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- FDA limits use of Janssen COVID-19 vaccine to certain individuals
- EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- FDA approves first generic of Symbicort to treat asthma and COPD